A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05810493

Enrollment

1500

Registered

2023-04-12

Start date

2022-01-01

Completion date

2023-05-31

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Brief summary

The purpose of the study is to conduct a descriptive analysis of the population of patients with an interstitial lung disease received in the pulmonary department of University hospital of Nice (France). Analysis and documentation of clinical forms of the disease, therapeutics used and evolutions.

Interventions

OTHERObservation

Follow-up of disease, therapeutics and evolution

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥ 18 years old * Diagnosis of interstitial lung disease according to the multidisciplinary monthly meeting for interstitial lung disease occuring at University hospital of Nice, France

Exclusion criteria

* Patient-led opposition to data collection

Design outcomes

Primary

Measure	Time frame
Build a retrospective cohort of patients with phenotyped interstitial Lung disease with longitudinal follow-up	2 years

Secondary

Measure	Time frame	Description
Follow-up of progression criteria according to diagnosis	2 years	Change in pulmonary functional tests

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026